| |

Ruxolitinib

Ruxolitinib Suppliers list
Company Name:Shanghai TaoSu Biochemical Technology Co., Ltd.  Gold
Tel:021-33632979
Email:info@tsbiochem.com
Products Intro: Product Name:Ruxolitinib (INCB018424)
CAS:941678-49-5
Purity:90% Package:1Mg
Company Name:Shanghai Witofly Chemical Co.,Ltd  Gold
Tel:
Email:sales@witofly.com
Products Intro: Product Name:INCB018424(Ruxolitinib)
CAS:941678-49-5
Purity:98% HPLC Package:10g
Company Name:Shanghai Boyle Chemical Co., Ltd.  Gold
Tel:Mr Qiu 86-21-50182298(Domestic Market)Miss Xu 86-21-50180596(Abroad Market)
Email:sales@boylechem.com
Products Intro: Product Name:Ruxolitinib
CAS:941678-49-5
Company Name:Dalian Meilun Biotech Co., Ltd.  Gold
Tel:0411-66771943；0411-66771942
Email:sales@meilune.com
Products Intro: Product Name:Ruxolitinib (INCB018424)
CAS:941678-49-5
Purity:>99% Package:20Mg,100Mg,1g
Company Name:NCE Biomedical Co.,Ltd.  Gold
Tel:4000-027-021 |24 hour enquiry :+86-13986109188 |English:+86-15623472865 |Japanese:+81-08033611988
Email:sales@ncebiomed.com
Products Intro: Product Name:INCB018424
CAS:941678-49-5
Purity:99% HPLC Package:50Mg,100Mg,500Mg,1g,5g,10g,50g,100g,500g,1kg Remarks:XYA0657
Ruxolitinib Basic information
Product Name:Ruxolitinib
Synonyms:Ruxolitinib;(R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile;(betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile;1H-Pyrazole-1-propanenitrile,.beta.-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-,(.beta.R)-;(3R)-3-(4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile;(3R)-3-cyclopentyl-3-(4-{7H-pyrrolo[2,3-d]pyriMidin-4-yl}-1H-pyrazol-1-yl)propanenitrile;INCB018424 (Ruxolitinib);Jakafi
CAS:941678-49-5
MF:C17H18N6
MW:306.371
EINECS:-0
Product Categories:APIs;Aromatics;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Tyrosine Kinase Inhibitors;Inhibitor;Antineoplastic;Anti-cancer&immunity
Mol File:941678-49-5.mol
Ruxolitinib Structure
Ruxolitinib Chemical Properties
density 1.40
Safety Information
MSDS Information
Ruxolitinib Usage And Synthesis
UsageA JAK family kinase inhibitor of JAK1, JAK2 and JAK3 with IC50s of 2.7 nM, 4.5 nM and 322 nM, respectively
UsageRuxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.
UsageINCB018424 is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM, >130-fold selectivity for JAK1/2 versus JAK3. Phase 3
Ruxolitinib Preparation Products And Raw materials
Tag:Ruxolitinib(941678-49-5) Related Product Information
AP24534(Ponatinib) Lenalidomide abiraterone Gefitinib Ibrutinib Bortezomib Y27632 (hydrochloride) MK-2206 2HCl Dasatinib Trametinib (GSK1120212) Tofacitinib (CP-690550,Tasocitinib)